UNITED THERAPEUTICS Corp UTHR
1 trading plan running, 92 Form 144 notices for $1.5B
10-Q, 10-K and Form 144What UTHR's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Dec 24, 2024 to Dec 31, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Christopher Patusky member of our Board of Directors |
Adopted 10b5-1 plan | Dec 18, 2025 | 10-K Feb 25, 2026 | ||
What the company wroteOn December 18, 2025, Christopher Patusky, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 4,910 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Dr. Martine Rothblatt Chairperson and Chief Executive Officer |
Adopted 10b5-1 plan | Nov 7, 2025 | 10-K Feb 25, 2026 | ||
What the company wroteOn November 7, 2025, Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 1,734,410 stock options and sell the shares of our common stock received, subject to certain conditions. These transactions would commence no earlier than March 2, 2026, and end no later than December 31, 2026, ahead of the anticipated expiration date of these options, which is March 15, 2027. The 1,734,410 stock options covered by this trading plan include options that will be owned by a trust of which Dr. Rothblatt was settlor and in which she has a pecuniary interest. | |||||
| Judy Olian member of our Board of Directors |
Adopted 10b5-1 plan | Nov 4, 2025 | 10-K Feb 25, 2026 | ||
What the company wroteOn November 4, 2025, Judy Olian, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 800 shares of our common stock, subject to certain conditions. | |||||
| James Edgemond Chief Financial Officer and Treasurer |
Adopted 10b5-1 plan | Oct 31, 2025 | 10-K Feb 25, 2026 | ||
What the company wroteOn October 31, 2025, James Edgemond, Chief Financial Officer and Treasurer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 268,750 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Christopher Causey member of our Board of Directors |
Adopted 10b5-1 plan | Sep 30, 2025 | 10-Q Oct 29, 2025 | ||
What the company wroteOn September 30, 2025, Christopher Causey, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 4,320 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Jan Malcolm member of our Board of Directors |
Adopted 10b5-1 plan | Sep 11, 2025 | 10-Q Oct 29, 2025 | ||
What the company wroteOn September 11, 2025, Jan Malcolm, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 720 shares of our common stock, subject to certain conditions. | |||||
| Paul Mahon Section 16 officer |
Adopted 10b5-1 plan | Aug 11, 2025 | 10-Q Oct 29, 2025 | ||
What the company wroteOn August 11, 2025, Paul Mahon, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 196,940 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| James Edgemond Section 16 officer |
Adopted 10b5-1 plan | Aug 5, 2025 | 10-Q Oct 29, 2025 | ||
What the company wroteOn August 5, 2025, James Edgemond, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 129,517 stock options and sell the shares of our common stock received, subject to certain conditions. | |||||
| Christopher Causey member of our Board of Directors |
Adopted 10b5-1 plan | Dec 24, 2024 | 10-K Feb 26, 2025 | ||
What the company wroteOn December 24, 2024, Christopher Causey, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 3,000 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Paul Mahon Section 16 officer |
Adopted 10b5-1 plan | Dec 24, 2024 | 10-K Feb 26, 2025 | ||
What the company wroteOn December 24, 2024, Paul Mahon, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 220,000 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| James Edgemond Section 16 officer |
Adopted 10b5-1 plan | Nov 6, 2024 | 10-K Feb 26, 2025 | ||
What the company wroteOn November 6, 2024, James Edgemond, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 111,500 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Christopher Patusky member of our Board of Directors |
Adopted 10b5-1 plan | Aug 27, 2024 | 10-Q Oct 30, 2024 | ||
What the company wroteOn August 27, 2024, Christopher Patusky, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 10,000 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Michael Benkowitz Section 16 officer |
Adopted 10b5-1 plan | Aug 7, 2024 | 10-Q Oct 30, 2024 | ||
What the company wroteOn August 7, 2024, trusts beneficially owned by Michael Benkowitz, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 201,679 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Raymond Dwek member of our Board of Directors |
Adopted 10b5-1 plan | Aug 2, 2024 | 10-Q Oct 30, 2024 | ||
What the company wroteOn August 2, 2024, Raymond Dwek, a member of our Board of Directors, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 10,000 stock options and sell the shares of common stock received, subject to certain conditions. | |||||
| Paul Mahon Section 16 officer |
Adopted 10b5-1 plan | Jun 20, 2024 | 10-Q Jul 31, 2024 | ||
What the company wroteOn June 20, 2024, Paul Mahon, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 91,250 STAP awards, subject to certain conditions. | |||||
| James Edgemond Section 16 officer |
Adopted 10b5-1 plan | May 17, 2024 | 10-Q Jul 31, 2024 | ||
What the company wroteOn May 17, 2024, James Edgemond, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 100,000 stock options, and to sell up to 80,000 shares of common stock received upon exercise of such stock options, subject to certain conditions. | |||||
| Raymond Dwek director |
Adopted 10b5-1 plan | Nov 27, 2023 | 10-K Feb 21, 2024 | ||
What the company wroteOn November 27, 2023, Raymond Dwek, a director of the company, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 10,000 STAP awards between April 8, 2024 and April 26, 2024, subject to certain conditions. These STAP awards are scheduled to expire on June 26, 2024. | |||||
| Dr. Martine Rothblatt Chairperson and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 4, 2023 | 10-Q Nov 1, 2023 | ||
What the company wroteOn August 4, 2023, Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 723,869 stock options and sell the shares of our common stock issued upon exercise between November 6, 2023 and August 31, 2024, subject to certain conditions. These stock options expire December 31, 2024. | |||||
| Dr. Martine Rothblatt Chairperson and Chief Executive Officer |
Adopted 10b5-1 plan | – | 10-Q Jul 30, 2025 | ||
What the company wroteOn May 2, 2025, Dr. Martine Rothblatt, our Chairperson and Chief Executive Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 294,000 stock options and sell the shares of our common stock received, subject to certain conditions. These stock options expire in March 2026. | |||||
| Michael Benkowitz Section 16 officer |
Adopted 10b5-1 plan | – | 10-Q Jul 30, 2025 | ||
What the company wroteOn June 3, 2025, trusts beneficially owned by Michael Benkowitz, a Section 16 officer, adopted a trading plan intended to satisfy Rule 10b5-1(c) to exercise up to 576,940 stock options and sell the shares of common stock received, subject to certain conditions. These stock options expire in March 2027. | |||||
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 9, 2026 | CHRISTOPHER PATUSKY Director |
1,210 | $702K |
| Nov 5, 2026 | PAUL MAHON Officer |
8,300 | $5.0M |
| Nov 2, 2026 | MARTINE ROTHBLATT Director, Officer |
119,410 | $71.5M |
| Oct 15, 2026 | PAUL MAHON Officer |
8,300 | $4.5M |
| Oct 1, 2026 | MARTINE ROTHBLATT Director, Officer |
209,000 | $113.3M |
| Oct 1, 2026 | PAUL MAHON Officer |
8,300 | $4.7M |
| Sep 17, 2026 | PAUL MAHON Officer |
8,300 | $4.1M |
| Sep 14, 2026 | NILDA MESA Director |
228 | $115K |
| Sep 3, 2026 | PAUL MAHON Officer |
8,300 | $4.0M |
| Sep 1, 2026 | MARTINE ROTHBLATT Officer |
199,500 | $101.8M |
| Aug 20, 2026 | PAUL MAHON Officer |
8,300 | $4.3M |
| Aug 6, 2026 | PAUL MAHON Officer |
8,300 | $4.3M |
| Aug 3, 2026 | MARTINE ROTHBLATT Director, Officer |
199,500 | $103.3M |
| Jul 16, 2026 | PAUL A. MAHON Officer |
8,300 | $4.4M |
| Jul 10, 2026 | JAN MALCOLM Director |
325 | $179K |
| Jul 2, 2026 | PAUL MAHON Officer |
8,300 | $4.6M |
| Jul 1, 2026 | MARTINE ROTHBLATT Director, Officer |
209,000 | $113.2M |
| Jun 18, 2026 | PAUL MAHON Officer |
8,300 | $4.5M |
| Jun 4, 2026 | PAUL MAHON Officer |
8,300 | $4.5M |
| Jun 1, 2026 | MARTINE ROTHBLATT Director, Officer |
199,500 | $111.1M |
| May 21, 2026 | PAUL MAHON Officer |
8,300 | $4.7M |
| May 12, 2026 | NILDA MESA Director |
258 | $150K |
| May 7, 2026 | PAUL MAHON Officer |
8,300 | $4.9M |
| May 4, 2026 | JAMES C EDGEMOND Officer |
148,750 | $84.8M |
| May 1, 2026 | MARTINE ROTHBLATT Officer |
190,000 | $108.6M |
| Apr 24, 2026 | CHRISTOPHER PATUSKY Director |
2,910 | $1.7M |
| Apr 17, 2026 | CHRISTOPHER PATUSKY Director |
1,000 | $579K |
| Apr 16, 2026 | PAUL MAHON Officer |
8,300 | $4.8M |
| Apr 2, 2026 | PAUL MAHON Officer |
8,300 | $4.7M |
| Apr 1, 2026 | MARTINE ROTHBLATT Director, Officer |
199,500 | $118.3M |
| Mar 30, 2026 | CHRISTOPHER CAUSEY Director |
1,300 | $786K |
| Mar 26, 2026 | TOMMY THOMPSON Director |
2,000 | $1.1M |
| Mar 23, 2026 | JAMES C EDGEMOND Officer |
120,000 | $62.9M |
| Mar 23, 2026 | JUDY OLIAN Director |
200 | $106K |
| Mar 19, 2026 | PAUL MAHON Officer |
8,300 | $4.4M |
| Mar 17, 2026 | JAN MALCOLM Director |
45 | $24K |
| Mar 16, 2026 | JUDY OLIAN Director |
200 | $107K |
| Mar 9, 2026 | JUDY OLIAN Director |
200 | $102K |
| Mar 5, 2026 | PAUL MAHON Officer |
8,300 | $4.0M |
| Mar 4, 2026 | CHRISTOPHER CAUSEY Director |
20 | $10K |
| Mar 4, 2026 | TOMMY THOMPSON Director |
2,000 | $979K |
| Mar 4, 2026 | RAYMOND KURZWEIL Director |
4,910 | $2.4M |
| Mar 3, 2026 | JAN MALCOLM Director |
50 | $25K |
| Mar 2, 2026 | MARTINE ROTHBLATT Director, Officer |
209,000 | $105.3M |
| Mar 2, 2026 | JUDY OLIAN Director |
200 | $102K |
| Feb 25, 2026 | CHRISTOPHER CAUSEY Director |
1,000 | $520K |
| Feb 19, 2026 | PAUL MAHON Officer |
8,300 | $4.0M |
| Feb 17, 2026 | JAN MALCOLM Director |
50 | $24K |
| Feb 5, 2026 | PAUL MAHON Officer |
8,300 | $4.0M |
| Feb 3, 2026 | JAN MALCOLM Director |
50 | $24K |
| Feb 2, 2026 | Michael Benkowitz Officer |
90,000 | $42.3M |
| Jan 20, 2026 | JAN MALCOLM Director |
50 | $23K |
| Jan 15, 2026 | PAUL MAHON Officer |
8,300 | $3.9M |
| Jan 6, 2026 | CHRISTOPHER CAUSEY Director |
1,000 | $510K |
| Jan 6, 2026 | JAN MALCOLM Director |
50 | $25K |
| Jan 5, 2026 | Michael Benkowitz Officer |
90,000 | $44.7M |
| Jan 2, 2026 | CHRISTOPHER CAUSEY Director |
1,000 | $500K |
| Jan 2, 2026 | PAUL MAHON Officer |
8,300 | $4.0M |
| Dec 29, 2025 | PAUL MAHON Officer |
11,000 | $5.6M |
| Dec 22, 2025 | LOUIS WADE SULLIVAN REVOCABLE TRUST Affiliate |
5,950 | $3.0M |
| Dec 19, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
2,000 | $1.0M |
| Dec 18, 2025 | TOMMY THOMPSON Director |
910 | $456K |
| Dec 18, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $2.0M |
| Dec 17, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $2.0M |
| Dec 16, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $2.0M |
| Dec 15, 2025 | CHRISTOPHER PATUSKY Director |
1,000 | $496K |
| Dec 15, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $2.0M |
| Dec 12, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $2.0M |
| Dec 11, 2025 | PAUL MAHON Officer |
11,000 | $5.3M |
| Dec 11, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 10, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 9, 2025 | NILDA MESA Director |
187 | $90K |
| Dec 9, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 8, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 5, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 4, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 3, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 2, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Dec 1, 2025 | JAMES EDGEMOND Officer |
105,000 | $51.0M |
| Dec 1, 2025 | Michael Benkowitz Officer |
112,500 | $54.7M |
| Dec 1, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 28, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $2.0M |
| Nov 26, 2025 | PAUL MAHON Officer |
11,000 | $5.3M |
| Nov 26, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 25, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 24, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 21, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 20, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 19, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 18, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 17, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
| Nov 14, 2025 | ROTHBLATT MARTINE A FOUNDER, CHAIRPERSON, AND CHIEF EXECUTIVE OFFICER |
4,000 | $1.9M |
Show the other 84 notices
From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/UTHR/export.csv") into a cell.